Back to search

Article

Association between zidovudine and adverse pregnancy outcomes/congenital malformations: A pharmacovigilance study using FAERS data

2025-08-24

Abstract excerpt

<h4>Background</h4> Zidovudine (AZT), a key antiretroviral drug used for HIV treatment and preventing mother-to-child transmission, has insufficient post-marketing pharmacovigilance regarding pregnancy outcomes and congenital disorders. <h4>Methods</h4> This pharmacovigilance study analyzed adverse event (AE) reports associated with zidovudine from the U.S. FDA Adverse Event Reporting System (FAERS) database (Q1...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0607e030-157a-50b5-b7a4-45cf015fae50
DOI
10.1101/2025.08.19.25334037
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Association between zidovudine and adverse pregnancy outcomes/congenital malformations: A pharmacovigilance study using FAERS dataDOI 10.1101/2025.08.19.25334037
Select a neighboring publication to make it the new centre.